METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Clinical trials for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can special diets reverse fatty liver in teens?
Disease control Not yet recruitingThis study tests two diets—one with essential amino acids and one low in sugar—to see if they can reduce liver fat and improve heart health in teens with fatty liver disease. About 102 children aged 11-17 with high BMI and liver fat will be randomly assigned to one or both diets …
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE2 • Sponsor: Corewell Health West • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
New drug ACT500 targets dual liver disease in early trial
Disease control Not yet recruitingThis early-stage study tests a new oral drug called ACT500 in 24 adults who have both fatty liver disease and chronic hepatitis B. The main goal is to check the drug's safety and how the body processes it. Participants will take the drug once daily for a short time, and researche…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE1 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New computer tool aims to catch hidden fatty liver in the ER
Diagnosis Not yet recruitingThis study tests a computer tool that helps emergency doctors notice fatty liver on scans, tell patients, and recommend next steps. About 4,700 adults with fatty liver found on an ER scan will take part. The goal is to improve diagnosis and follow-up care for this often-overlooke…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Northwestern University • Aim: Diagnosis
Last updated May 26, 2026 04:38 UTC
-
Morning or evening workout? new study tests which burns more liver fat
Symptom relief Not yet recruitingThis study looks at whether exercising in the morning or evening is better for reducing liver fat in postmenopausal women with fatty liver disease. 63 women will be placed into morning exercise, evening exercise, or a no-exercise group for 12 weeks. Researchers will measure chang…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Universidad de Almeria • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC
-
New ultrasound tech could replace liver biopsies for fatty liver patients
Knowledge-focused Not yet recruitingThis study tests two noninvasive ultrasound devices to measure liver stiffness and inflammation in people with fatty liver disease. About 95 adults will get same-day scans with both machines to see if results match. The goal is to find a painless way to assess liver damage withou…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 07:03 UTC
-
Could early drug combo save lives in diabetes patients?
Knowledge-focused Not yet recruitingThis study uses health records to compare adding a second diabetes drug early in adults with obesity, type 2 diabetes, heart-kidney issues, and fatty liver disease. Researchers will look at whether adding a GLP-1 or SGLT2 drug within 90 days of starting treatment lowers the risk …
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Chung Shan Medical University • Aim: Knowledge-focused
Last updated May 26, 2026 06:47 UTC
-
Virtual twins could predict liver and heart risks
Knowledge-focused Not yet recruitingThis observational study aims to create a detailed virtual model of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) to better understand how the disease progresses and to predict heart problems. Researchers will follow over 7,700 adults with MASLD, using tests an…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Knowledge-focused
Last updated May 26, 2026 06:44 UTC
-
Blood test may predict heart risk in fatty liver patients
Knowledge-focused Not yet recruitingThis study looks at whether a routine blood test measuring mean platelet volume (MPV) can help predict acute coronary syndrome (heart attack or unstable angina) in people with metabolic dysfunction-associated steatotic liver disease (MASLD). Researchers will compare MPV levels in…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated May 26, 2026 04:38 UTC
-
Scientists probe Insulin's role in liver fat and sugar
Knowledge-focused Not yet recruitingThis study looks at how changing insulin levels affects the liver's production of sugar and fat in people with insulin resistance and fatty liver disease. About 36 adults with overweight or obesity will undergo two procedures where insulin is either kept high or lowered by half. …
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE1 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC
-
New ultrasound technique could replace MRI for fatty liver diagnosis
Knowledge-focused Not yet recruitingThis study will test a new ultrasound method to measure liver stiffness and fat content in 145 healthy volunteers and patients with fatty liver disease. The goal is to see if ultrasound can work as well as MRI or the current standard FibroScan. If successful, it could offer a che…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC